Vista Pharmaceuticals Ltd

NSE: VISTAPH · BSE: 524711 · Pharmaceuticals & Biotechnology · 9 announcements

Share price: ₹6.40
Market cap: ₹39.39 Cr
Revenue (annual): ₹5.40 Cr
Net profit (annual): ₹-12.06 Cr
P/E (TTM): -3.4×Sector 47.4×
Promoter holding: 21.19%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Other Announcement 2 Board Meeting Date 2 Management Change 1 Debt & Borrowing 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 Apr 2026 12:00 IST BSE

Debt & Borrowing

Vista Pharmaceuticals Debt & Borrowing

Vista Pharmaceuticals Limited (BSE: 524711) submitted its annual disclosure for FY 2025-26, confirming it does not meet the criteria for a 'Large Corporate' under SEBI norms. The company reported nil incremental borrowing and no penalties for the current block period.

Read the filing ↗